her2 breast cancer: neratinib’s role as adjuvant therapy
Published 5 years ago • 831 plays • Length 8:12Download video MP4
Download video MP3
Similar videos
-
3:25
role for neratinib following adjuvant dual-targeted her2 therapy
-
4:09
her2 breast cancer: neratinib patient selection
-
3:58
post-adjuvant therapy for her2 breast cancer
-
2:18
use of neratinib in her2-positive breast cancer
-
0:52
dr. gradishar on the role of neratinib in the treatment of her2 breast cancer
-
1:37
dr. traina on conversations on extended adjuvant therapy with neratinib in her2 breast cancer
-
8:21
extended adjuvant therapy for her2-positive breast cancer
-
9:35
neratinib in her2 breast cancer
-
1:08
dr. isaacs discusses the role of neratinib in her2 breast cancer
-
8:23
adjuvant therapy for her2-driven breast cancer
-
1:14
dr. hamilton on how neratinib targets her2 breast cancer
-
1:51
eleanor interim analysis: real-world study of adjuvant neratinib in her2 /hr early breast cancer
-
2:51
breast cancer: extended adjuvant therapy and cost factors
-
6:47
extended adjuvant therapy for her2-positive early breast cancer
-
1:19
dr. pegram discusses the use of neratinib in her2 breast cancer
-
1:49
dr. rahman on pertuzumab and neratinib in her2 breast cancer
-
6:41
the emerging role of neratinib in her2 mbc
-
0:53
eleanor: real-world study of extended adjuvant neratinib in her2 /hr early breast cancer
-
1:09
dr. dang on neratinib in patients with her2 breast cancer